TXA Central is a resource for health professionals caring for patients with acute severe bleeding
Bleeding Conditions
The effectiveness and safety of tranexamic acid (TXA) in the treatment and prevention of acute severe bleeding is being evaluated in a suite of large–scale trials – some of these trials are completed with the results available and others are on-going
Learn about the different areas where TXA research has been conducted by following the links below